German court makes SPC decision of ‘fundamental importance’

08-03-2018

The German Federal Patent Court has set aside a decision by the German Patent and Trade Mark Office (DPMA) to reject a supplementary protection certificate (SPC) that GSK Biologicals had applied for, in a decision of “fundamental importance”.


German Federal Patent Court, German Patent and Trademark Office, patent, supplementary protection certificate, Hoffmann Eitle, Bianca-Lucia Vos, Klemens St

LSIPR